SRTS today
$3.41+$0.11 (+3.33%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minBearish
5 minStrong Bullish
Daily trend turns down below $2.66
Key levels
Resistance$4.20
Resistance$3.72
Support$3.04
Support$2.68
Latest news & SEC filings
ProductSensus Healthcare's SRT-100 Selected by Qualderm for Skin Cancer Care
NewsSensus Healthcare trading halted by circuit breaker, shares up 30.18%
EarningsSensus Healthcare Posts Second-Quarter 2026 Results
SEC FilingSensus Healthcare, Inc. filed an insider trading report (Form 4)
All SRTS news →About Sensus Healthcare
Sensus Healthcare is a medical device company that builds radiation therapy equipment using a proprietary X-ray approach. Its devices, sold under the SRT family of brand names, are designed for skin cancer and keloid scar treatment. Buyers include dermatology clinics, radiation oncologists, and plastic surgeons, mainly in the United States and other nations. The company also provides service contracts and a revenue-share option supplying equipment and clinical staffing.
Based on the company's 10-K filed Mar 4, 2026.
Nasdaq · Healthcare
Sensus Healthcare, Inc. (SRTS)
What Is the Price Target for SRTS?
SEPT Low Target
$3.40
SEPT Mid Target
$4.00
SEPT High Target
$4.60
Analyst Consensus
$4.00
Is SRTS a Buy or Sell Right Now?
Thesis
- •Revenue growing -34.3% YoY with STRONG trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SRTS.
Start Free Trial →Is SRTS Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$4.83
39
Moat Score
NONE
5/9
Piotroski Score
6.8
Altman Z-Score
What Is Smart Money Doing with SRTS?
Insider Signal
BUYING
6 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Sachetta Eric | director | Buy | 27,304 | $97K | Aug 31, 2026 |
| Sachetta Eric | director | Buy | 37,537 | $129K | Aug 28, 2026 |
| Sachetta Eric | director | Buy | 10,925 | $35K | Aug 27, 2026 |
| Sachetta Eric | director | Buy | 9,708 | $32K | Aug 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SRTS Growth Story
Revenue YoY
-34.3%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-214.63%
FCF Growth YoY
130.0%
Revenue Trend
STRONG
Dark Pool Trades for SRTS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SRTS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:56:49 | $3.41 | 1,000 | $$3K | BUY |
| 20:49:52 | $3.40 | 1,800 | $$6K | SELL |
| 20:48:13 | $3.42 | 2,000 | $$7K | BUY |
| 20:48:02 | $3.40 | 1,000 | $$3K | SELL |
| 20:43:33 | $3.42 | 1,000 | $$3K | MIDPOINT |
5 dark pool trades shown · $$23K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for SRTS
PREVIEWSEPT Investing provides real-time options flow tracking for SRTS, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $3 | Apr 16 | 156 | $$2600 | 26 | SWEEP |
1 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Sensus Healthcare, Inc. (SRTS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SRTS — frequently asked questions
What is SRTS stock price today?
Sensus Healthcare, Inc. (SRTS) is at $3.41, up 3.33% (+$0.11) at the Nov 11, 2026 close.
Why is SRTS stock moving today?
Latest SRTS news — Nov 11, 2026: Sensus Healthcare's SRT-100 Selected by Qualderm for Skin Cancer Care · Nov 3, 2026: Sensus Healthcare trading halted by circuit breaker, shares up 30.18%
What is the SRTS price target?
The average analyst price target for SRTS is $4.00, ranging from $4 to $4, based on 1 analysts. Latest: Lake Street maintains on Aug 14, 2026.
What do analysts rate SRTS?
Analyst ratings for SRTS: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did SRTS beat earnings?
SRTS last reported on Aug 13, 2026: EPS -$0.53 vs -$0.13 expected — a miss of 324.0%.
Does SRTS pay a dividend?
SRTS does not currently pay a dividend.
What are SRTS support and resistance levels?
Support: $3.04, $2.68. Resistance: $3.72, $4.20, $4.90.
What are insiders doing with SRTS?
Insider activity: BUYING, 6 buys and 0 sells in the last 90 days.
What is the latest news on SRTS?
Nov 11, 2026: Sensus Healthcare's SRT-100 Selected by Qualderm for Skin Cancer Care · Nov 3, 2026: Sensus Healthcare trading halted by circuit breaker, shares up 30.18% · Nov 1, 2026: Sensus Healthcare Posts Second-Quarter 2026 Results